Influence of bioengineering and bioinformatics technologies on public health status
Year: 2025, volume 21 Issue: №2 Pages: 194-200
Heading: Public health, organization and sociology of health care Article type: Review
Authors: Vidiasheva I.V., Erugina M.V., Arkhangelskaya A.A., Tupikin D.V., Strizhevskaya V.N., Maradudin M.S., Romanova Kh.S.
Organization: Saratov State Medical University
Heading: Public health, organization and sociology of health care Article type: Review
Authors: Vidiasheva I.V., Erugina M.V., Arkhangelskaya A.A., Tupikin D.V., Strizhevskaya V.N., Maradudin M.S., Romanova Kh.S.
Organization: Saratov State Medical University
Summary:
Objective: identify the most significant bioengineering and bioinformatics technologies aimed at preserving and strengthening the health of the population. Methodology for writing a review. The systematic review was performed on the PRISMA methodology applying the PubMed, eLibrary, Google Scholar, CyberLeninka databases. The search period was from 2006 to 2025. 50 sources were used to write the review. Conclusion. A review of scientific works suggests a significant potential of the development of bioengineering and bioinformatics technologies to improve population health. Analysis of studies focused on genome editing revealed the emergence of new technologies (CRISPR/Cas9, CAR-T) in the treatment of previously incurable and orphan diseases. Bioinformatics researches, related to the genome/clinic database (TCGA, GWAS), focus on the identifying of risk factors and predictors of human diseases. The modern tendency in regenerative medicine is aimed at the creating of the individual products for tissues and organs recovering (3D-printed models). They help to reduce the rehabilitation periods and return the patients to the working life. At the present, there are pressing issues of assessment the medical, economic and social effectiveness of presented here technologies. They can be integrated into healthcare system after justification of the organizational technologies.
Bibliography:
1. van Dam S, Vosa U, van der Graaf A, et al. Gene co-expression analysis for functional classification and gene-disease predictions. Brief Bioinform. 2018;19(4):575-92. DOI:10.1093/bib/bbw139
2. Kascheeva TK, Kuznetzova TV, Baranov VS. New technologies and trends of prenatal diagnostics. Journal of Obstetrics and Women's Diseases. 2017;66(2):33-9. DOI:10.17816/JOWD66233-39
3. Grossman RL, Heath АР, Ferretti V, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375 (12):1109-12. DOI:10.1056/NEJMp1607591
4. Bradfield JP, Qu H-Q, Wang K, et al. A genome-wide me-ta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 2011 ;7(9):e1002293. DOI:10.1371/journal.pgen.1002293
5. Gong L, Chen B, Zhang J, et al. Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells. J Extracell Vesicles. 2020;9(1): 1800971. DOI:10.1080/20013078.2020.1800971
6. Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer's disease. J Prev Alzheimers Dis. 2022;9(2):197-210. DOI:10.14283/jpad.2022.30
7. Bowles DE, McPhee SW, Li C, et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther. 2012;20(2):443-55. DOI:10.1038/mt.2011.237
8. Constable IJ, Lai CM, Magno AL, et al. Gene therapy in neovascular age-related macular degeneration: Three-year follow-up of a phase 1 randomized dose escalation trial. Am J Ophthalmol. 2017;177:150-8. DOI:10.1016/j.ajo.2017.02.018
9. Mclntosh J, Lenting PJ, Rosales C, et al. Therapeutic levels of FVIII following a single peripheral vein administration of
rAAV vector encoding a novel human factor VIII variant. Blood. 2013; 121 (17):3335-44. DOI: 10.1182/blood-2012-10-462200
10. Epstein AL, Haag-Molkenteller С Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB). Cell. 2023; 186(17):3523-3523. e1. DOI:10.1016/j.cell.2023.07.031
11. Shieh PB, Kuntz NL, Dowling JJ, et al. Safety and efficacy of gene replacement therapy for X-linked myotubular myopa-thy (ASPIRO): A multinational, open-label, dose-escalation trial. Lancet Neurol. 2023;22(12):1125-39. DOI:10.1016/S1474-4422 (23)00313-7
12. Kobelt D, Pahle J, Walther W. A brief introduction to current cancer gene therapy. Methods Mol Biol. 2022;2521:346-58. DOI: 10.1007/978-1 -0716-2441-8_1
13. Katayama S, Watanabe M, Kato Y, et al. Engineering of zinc finger nucleases through structural modeling improves genome editing efficiency in cells. Adv Sci (Weinh). 2024;11 (23):e2310255. DOI:10.1002/advs.202310255
14. Stadtmauer EA, Fraietta JA, Davis MM, et al. CRISPR-engineered T cells in patients with refractory cancer. Science. 2020;367(6481):eaba7365. DOI:10.1126/science.aba7365
15. George LA, Ragni MV, Rasko JEJ, et al. Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B. Mol Ther. 2020;28(9):2073-82. DOI:10.1016/j.ymthe.2020.06.001
16. Smith AJ, Bainbridge JW, AN RR. Gene supplementation therapy for recessive forms of inherited retinal dystrophies. Gene Ther. 2012;19(2):154-61. DOI:10.1038/gt.2011.161
17. Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713-22. DOI:10.1056/NEJMoa1706198
18. Wang M, Munoz J, Goy A, et al. CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma. N Engl J Med. 2020;382(14):1331-42. DOI:10.1056/NEJMoa1914347
19. Stepanova VM, Volkov DV, Osipova DS, et al. Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning. Mol Ther Oncol. 2024;32(3):200843. DOI:10.1016/j.omton.2024.200843
20. Cao Y, Sun H, Zhu H, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: A phase I clinical trial. Stem Cell Res Ther. 2018;9(1 ):192-9. DOM 0.1186/s13287-018-0904-3
21. Douglas TEL, Sobczyk K, tapa A, et al. Ca: Mg: Zn: СОЗ and Ca: Mg: СОЗ-tri- and bi-elemental carbonate microparticles for novel injectable self-gelling hydrogel-microparticle composites for tissue regeneration. Biomed Mater. 2017;12(2):025015. DOI:10.1088/1748-605X/aa6200
22. Gupta SK, Mishra NC, Dhasmana A. Decellularization methods for scaffold fabrication. Methods Mol Biol. 2018;1577:1-10. DOI:10.1007/7651_2017_34
23. Lin T, Liu S, Chen S, et al. Hydrogel derived from porcine decellularized nerve tissue as a promising biomaterial for repairing peripheral nerve defects. Acta Biomater. 2018;73:326-38. DOI:10.1016/j.actbio.2018.04.001
24. Gupta SK, Kumar R, Mishra NC. Influence of quercetin and nanohydroxyapatite modifications of decellularized goat-lung scaffold for bone regeneration. Mater Sci Eng С Mater Biol Appl. 2017;71:919-28. DOM 0.1016/j.msec.2016.10.085
25. Chani B, Puri V, Sobti RC, et al. Decellularized scaffold of cryopreserved rat kidney retains its recellularization potential. PLoS One. 2017;12(3):e0173040. DOM0.1371/journal.pone.0173040
26. Song JS, Takimoto K, Jeon M, et al. Decellularized human dental pulp as a scaffold for regenerative endodontics. J Dent Res. 2017;96:640-6. DOM 0.1177/0022034517693606
27. Gauvin R, Chen YC, Lee JW, et al. Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials. 2012;33 (15):3824-34. DOM0.1016/j.biomaterials.2012.01.048
28. Vidiasheva IV, Abalymov AA, Kurochkin MA, et al. Transfer of cells with uptaken nanocomposite, magnetite-nanoparticle functionalized capsules with electromagnetic tweezers. Biomater Sci. 2018;6(8):2219-29. DOM0.1039/c8bm00479j
29. Kurenov SN, lonita C, Sammons D, Demmy TL. Three-dimensional printing to facilitate anatomic study, device development, simulation, and planning in thoracic surgery. J Thorac Cardiovasc Surg. 2015;149(4):973-9. e1. DOI:10.1016/j.jtcvs.2014.12.059
30. Gupta S, Goil P. Use of 3D printing and virtual 3D imaging to aid mandibular reconstruction; A low cost, easy and
reproducible methodology at our centre. J Plast Reconstr Aesthet Surg. 2021;74(5):1101-60. DOI:10.1016/j.bjps.2020.10.078
31. Auricchio F, Marconi S. 3D printing: clinical applications in orthopaedics and traumatology. EFORT Open Rev. 2017;1 (5):121-7. DOI:10.1302/2058-5241.1.000012
32. Frame M, Huntley JS. Rapid prototyping in orthopaedic surgery: A user's guide. Sci World J. 2012;(3):838575. DOI:10.1100/2012/838575
33. De La Pena A, De La Pena-Brambila J, Perez-De La Torre J, et al. Low-cost customized cranioplasty using a 3D digital printing model: A case report. 3D Print Med. 2018;4(1):4-13. DOM 0.1186/S41205-018-0026-7
34. Dey M, Ozbolat IT. 3D bioprinting of cells, tissues and organs. Sci Rep. 2020;10 (1):14023. DOI:10.1038/s41598-020-70086-y
35. Wu C, Luo M, Liu Y, etal. Application of a 3D-printed eye model for teaching direct ophthalmoscopy to undergraduates. GraefesArch Clin Exp Ophthalmol. 2022;260(7):2361-8. DOM0 .1007/S00417-021-05538-w
36. Malecki M. 'Above all, do no harm': Safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther. 2014;5(3):73-9. DOI:10.1186/scrt462
37. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. DOI:10.1016/j.cell. 2006.07.024
38. Menasche P, Vanneaux V, Hagege A, et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report. Eur Heart J. 2015;36 (30):2011-7. DOI:10.1093/eurheartj/ehv189
39. Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385(9967):509-16. DOI:10.1016/S0140-6736(14)61376-3
40. Veres A, Faust AL, Bushnell HL, et al. Charting cellular identity during human in vitro (3-cell differentiation. Nature. 2019;569(7756):368-73. DOI:10.1038/s41586-019-1168-5
41. Korsakov IN, Samchuk DP, Pulin AA, et al. The effect of autologous gingival cells with myogenic potential on the regeneration of skeletal muscle tissue. Genes and Cells. 2017;12(2):71-81. DOM 0.23868/201707017
42. Forest DL, Johnson LV, Clegg DO. Cellular models and therapies for age-related macular degeneration. Dis Model Mech. 2015;8(5):421-7. DOM0.1242/dmm.017236
43. Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214-8. DOI:10.1038/na-ture12213
44. Pinero J, Bravo A, Queralt-Rosinach N, et al. DisGeNET A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45 (D1):D833-9. DOI:10.1093/nar/gkw943
45. Wang Y, Chen S, Deng N, et al. Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data. PLoS One. 2013;8(11):e78518. DOI:10.1371/journal.pone.0078518
46. Kolosnitsyna MG, Chubarov MYu. Socio-economic factors of mortality from infectious diseases in the Russian regions. Social Aspects of Population Health. 2021 ;67 (5):2. DOI: 10.21045/2071-5021-2021-67-5-2
47. Chan JFW, Kok КН, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-36. DOM 0.1080/22221 751.2020.1719902. Erratum in: Emerg Microbes Infect. 2020;9 (1):540. DOI: 10.1080/22221751.2020.1737364
48. Huang H, Nguyen T, Ibrahim S, et al. DMAP: A connectivity map database to enable identification of novel drug repositioning candidates. ВМС Bioinformatics. 2015;16(S13):S4. DOI:10.1186/1471-2105-16-S13-S4
49. Kennedy AD, Pappan KL, Donti TR, et al. Elucidation of the complex metabolic profile of cerebrospinal fluid using an un-targeted biochemical profiling assay. Mol Genet Metab. 2017;121 (2):83-90. DOI:10.1016/j.ymgme.2017.04.005
50. Lin YS, Kerr SJ, Randolph T, et al. Prediction of intravenous busulfan clearance by endogenous plasma biomarkers using global pharmacometabolomics. Metabolomics. 2016;12 (10):161. DOI:10.1007/S11306-016-1106-6
| Attachment | Size |
|---|---|
| 2025_02_194-200.pdf | 560.08 KB |
Русский
English